ETC
TNXP icon

Exchange Traded Concepts’s Tonix Pharmaceuticals TNXP Stock Holding History

Exchange Traded Concepts’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$9.03K – 1277
2022
Q4 		$9.03K Buy
+1
New +$8.63K ﹤0.01% 1006
2022
Q3 		– Hold
0
– – – 1101
2022
Q2 		– Hold
0
– – – 1189
2022
Q1 		– Hold
0
– – – 1175

Other funds holding TNXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Exchange Traded Concepts's TNXP Position: Q1 2023 in Review

Exchange Traded Concepts sold out of Tonix Pharmaceuticals (TNXP) in Q1 2023, closing a stake of 1 share — an estimated $9.03K sold.

Exchange Traded Concepts first reported a position in TNXP in Q4 2022 and held it in 1 quarter. The position peaked at $9.03K in Q4 2022. 18 funds tracked by Wall St. Rank hold TNXP as of Q1 2023.

  • Exchange Traded Concepts reported no remaining Tonix Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 1 Tonix Pharmaceuticals share in Q1 2023, an estimated $9.03K.
  • Exchange Traded Concepts first reported a position in Tonix Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Exchange Traded Concepts's Tonix Pharmaceuticals position peaked at $9.03K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2023.

Based on Exchange Traded Concepts's 13F filing for Q1 2023, filed 12 Apr 2023.